Tuesday, February 23, 2021 3:44:12 PM
You comments regarding the address are valid, but that is not enough to call a company a fake.
ENKS made $22M "net" revenue last year; they have over $96M in assets; and, an additional $39.5M in retained earnings that have not yet been reported as revenue. The $39.5M are earnings held in their overseas accounts and are being used as capital to finance work.
Their financials reflect their past accomplishments and not the value of the future projects, such as the Solar Plant, Hydrogen Plant and 5G network build out that they were awarded in Ukraine.
ENKS work is predominantly overseas and so are the majority of their offices. Their recent PRs explain that their North American addresses are satellite offices.
Their financials have been validated by their lawyer under oath. They will be current in the next few days validating that their disclosures accurately reflect their operations.
You should compare the ENKS balance sheet to other OTC stocks that you feel are stronger. I doubt there are many OTC stocks with stronger financials.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM